Latest News from EMD
We are amid the “triple-demic” of respiratory illnesses season that includes a significant increase in U.S. COVID-19 hospitalizations alongside annual seasonal surges in respiratory viruses like influenza and respiratory syncytial virus (RSV). YSPH Professor Sten Vermund offers timely guidance on how people can best protect themselves in this opinion piece.
- November 22, 2023Source: ABC News
There are a few well-known mitigation measures you can follow to keep yourself and your loved ones safe during the holidays. YSPH Dr. Albert Ko provides some guidance.
- November 21, 2023Source: New Haven Independent
Roughly $10 million in federal aid will flow to the New Haven area over the next five years to help municipal health departments take a regional approach in combating the opioid epidemic. YSPH Professor Robert Heimer is helping to lead the effort.
- November 20, 2023Source: CBS News
Thousands of Ukrainian children have reportedly been taken from their homes and moved to camps in Russia or Belarus since the start of the war. Nathaniel Raymond, director of the Yale Humanitarian Research Lab at the Yale School of Public Health, joined CBS News to discuss.
- November 20, 2023
Pills2Me is a Yale School of Public Health innovation success story. The company received its initial support and funding in 2020 from InnovateHealth Yale, YSPH’s social entrepreneurship program, and was recently named one of the U.S. recipients of the Google for Startups Black and Latino Founders Fund for 2023.
- November 16, 2023Source: Reuters
More than 2,400 children from Ukraine aged between six and 17 years old have been taken to 13 facilities across Belarus since Russia's full-scale invasion of Ukraine in early 2022, according to new research published by the Yale School of Public Health's Humanitarian Research Lab.
- November 16, 2023
A new study reveals significant insights into the challenges that can occur for hepatitis C virus (HCV) micro-elimination efforts in people with HIV (PWH). Due to the opioid epidemic, the prevalence of co-infection with HIV and HCV has been increasing. If left untreated, HCV infection can lead to liver damage, cancer, and death. Although HIV requires lifelong therapy, HCV can be cured with a few months of oral medications.
- November 15, 2023
Yale School of Public Health partners with Kazakhstan university on advanced research training to address HIV
The Yale School of Public Health is partnering with Nazarbayev University School of Medicine in Astana, Kazakhstan on an advanced research training program that will support promising scientists and clinicians interested in phylogeny of viruses and molecular epidemiology.
- November 10, 2023Source: The Washington Post
The Food and Drug Administration has approved the world’s first vaccine to prevent chikungunya, a mosquito-borne illness that can cause debilitating joint pain for months to years. YSPH Dr. Albert Ko comments.
- November 09, 2023Source: Yahoo News
Norovirus, the infamous wintertime stomach bug, is slowly on the rise in the United States. YSPH Dr. Albert Ko suggests one possible reason for the increase.